Skip to main content

Table 4 Adjusted associations of residency and secondary exposures with treatment success and loss to follow-up (n = 5490)

From: Tuberculosis among economic migrants: a cross-sectional study of the risk of poor treatment outcomes and impact of a treatment adherence intervention among temporary residents in an urban district in Ho Chi Minh City, Viet Nam

 

Treatment success

Loss to follow-up

aRR‡

95% CI

p-valueÞ

aOR‡

95% CI

p-valueÞ

Residency

 KT1¥

1.00

  

1.00

  

 KT2

0.95

[0.88, 1.02]

0.163

1.86

[1.03, 3.36]

0.041

 KT3

1.01

[0.97, 1.05]

0.685

0.59

[0.30, 1.17]

0.134

 KT4

0.95

[0.92, 0.99]

0.010

1.98

[1.44, 2.72]

< 0.001

Sex

 Male¥

1.00

  

1.00

  

 Female

1.02

[1.00, 1.05]

0.078

0.80

[0.60, 1.07]

0.139

Age

  < 25 years¥

1.00

  

1.00

  

 25–34 years

1.00

[0.97, 1.04]

0.881

1.00

[0.68, 1.46]

0.982

 35–44 years

1.01

[0.97, 1.04]

0.622

0.73

[0.48, 1.11]

0.142

 45–54 years

1.00

[0.96, 1.03]

0.863

0.59

[0.37, 0.93]

0.024

  > 55 years

0.93

[0.89, 0.96]

< 0.001

0.58

[0.36, 0.93]

0.024

Patient type┼

 New¥

1.00

  

1.00

  

 Relapse

0.89

[0.84, 0.94]

< 0.001

1.09

[0.69, 1.73]

0.705

 Failure

0.62

[0.52, 0.75]

< 0.001

1.77

[0.80, 3.95]

0.160

 LTFU

0.87

[0.73, 1.02]

0.085

1.79

[0.69, 4.62]

0.228

 Unknown

0.97

[0.92, 1.02]

0.198

1.42

[0.86, 2.36]

0.171

 Transfer in

0.88

[0.81, 0.96]

0.003

1.48

[0.85, 2.60]

0.170

Type of TB§,Π

 AFB(+)¥

1.00

  

1.00

  

 AFB(−)

1.06

[1.03, 1.09]

< 0.001

0.79

[0.55, 1.12]

0.184

 EP

1.05

[1.02, 1.08]

0.001

0.77

[0.55, 1.08]

0.126

HIV/AIDS¶

 No/Unknown¥

1.00

  

1.00

  

 Yes

0.77

[0.73, 0.82]

< 0.001

2.18

[1.55, 3.06]

< 0.001

Diabetes

 No/Unknown¥

1.00

  

1.00

  

 Yes

0.96

[0.91, 1.02]

0.159

1.15

[0.65, 2.03]

0.619

  1. Notes
  2. ‡Adjusted summary RR and OR by log binomial and logistic regression, respectively, adjusted by all other variables listed in the table;
  3. ÞWald test;
  4. ¥Referent;
  5. ┼Failure = Retreatment after category I treatment failure; LTFU = Retreatment after loss to follow-up; Unknown = Retreatment with unknown/uncertain exposure to anti-TB drugs;
  6. §AFB(+) = Sputum smear positive; AFB(−) = Sputum smear negative; EP = Extra-pulmonary TB;
  7. Πnot included in the final convergent multivariate model with LTFU as the primary outcome
  8. ¶Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome;